Skip to main content
Signal8

enVVeno Medical Secures Transformational U.S. Patent for enVVe System, Strengthening Competitive Moat Ahead of Launch of Historic FDA Pivotal Trial

$NVNOPress releaseJul 7, 2026, 8:29 AM ETRead the release

enVVeno Medical announced the issuance of U.S. Patent No. 12,575,932, covering key components of its enVVe transcatheter replacement venous valve system and associated methods for treating deep venous insufficiency. The patent protection encompasses the valve, support frame, crimping system, and delivery mechanisms, reinforcing the company's competitive position as it prepares for the TAVVE pivotal study under an FDA-approved IDE.

Key figures

Data timeline
End of Q4 2026
Patent number
12,575,932

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.